Abbreviations
- MCAD :
-
medium-chain acyl-CoA dehydrogenase
References
Allen RJ, Wong P, Rathenberg SP, Dimauro S, Headington JT (1980) Progressive neonatal leukoencephalomyopathy due to absent methylenetetrahydrofolate reductase, responsive to treatment. Ann Neurol 8:211
Becker CM, Harris RA (1983) Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 223:381–392
Chalmes RA, Roe CR, Stacey TE, Hoppel CL (1984) Urinary excretion ofl-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency ofl-carnitine. Pediatr Res 18:1325–1328
Duran M, Mitchell G, Klerk JBC de (1985) Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr 107:397–404
Fritz IB, Schultz SK, Srere PA (1963) Properties of partially purified carnitine acetyltransferase. J Biol Chem 238:2509–2517
Gregersen N (1985) The acyl-CoA dehydrogenase deficiencies. Scand J Lab Invest [Suppl] 174:1–60
Gregerson N, Mortenson PB, Kolvraa S (1983) On the biologic origin of C6−C10 dicarboxylic and C6−C10-w-1-hydroxymonocarboxylic acids in human and rat with acyl CoA dehydrogenation deficiencies; in vitro studies in the w- and w-1 oxidation of medium chain (C6−C12) fatty acids in human and rat liver. Pediatr Res 17:828–834
Lehotay DC, Fisher LJ (1991) Sodium pivalate-induced carnitine deficiency in rats and guinea pigs. 2nd Internat. Symposium on Clinical, Biochemical and Molecular Aspects of Fatty Acid Oxidation. Philadelphia 3–6 November 1991
McGarry JD, Foster DW (1976) An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 17: 277–281
Melegh B, Kerner J, Bieber LL (1987) Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol 36:3405–3409
Millington DS, Bohan TP, Roe CR, Yergey AL, Liberato DJ (1985) Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography mass spectrometry. Clin Chim Acta 145:69–76
Millington DS, Roe CR, Maltby DA (1987) Characterization of new diagnostic acylcarnitines in patients with β-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomed Environm Mass Spectrom 14:711–716
Rebouche CJ, Paulson DJ (1986) Carnitine metabolism and function in humans. Ann Rev Nutr 6:41–66
Roe CR, Millington DS, Maltby DA, Kahler SG, Bohan TP (1984)l-Carnitine therapy in isovaleric acidemia. J Clin Invest 74:2290–2295
Roe CR, Millington DS, Maltby DA, Bohan TP, Hoppel CL (1984)l-Carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 73: 1785–1788
Roe CR, Millington DS, Maltby DA, Bohan TP, Kahler SG, Chalmers RA (1985) Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 19:459–466
Roe CR, Millington DS, Maltby DA (1986) Diagnostic and therapeutic implications of acylcarnitine profiling in organic acidurias associated with carnitine insufficiecy. In: Borum PR ed. Clinical aspects of human carnitine deficiency. Pergamon Press, Elmsford, pp 97–107
Roe CR, Millington DS, Maltby DA, Kinnebrew P (1986) Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. J Pediatr 108:13–18
Roe C, Millington DS, Maltby DA (1986) Identification of 3-methylglutaryl-carnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme-A lyase deficiency. J Clin Invest 77:1391–1394
Roe CR, Millington DS, Kahler SG, Kodo N, Norwood DL (1991) Carnitine and the organic acidurias. In: Schaub J, Hoof F van, Vis HL (eds) Inborn errors of metabolism. Raven Press, New York, pp 57–68
Schmidt-Sommerfeld E, Penn D, Kerner J, Bieber LL, Rossi TM, Lebenthal E (1989) Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state andl-carnitine therapy. J Pediatr 115:577–582
Sekas G, Paul HS (1991) Pyrimethamine and sulfadiazine administration produces carnitine deficiency. Carnitine Symposium Atlanta, Georgia, 19–21 April 1991
Stanley CA, Hale DE, Coates PM (1983) Mediumchain acyl CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res 7: 877–884
Sousa C de, English NR, Stacey TE, Chalmers RA (1990) Measurement ofl-carnitine and acylcarnitines in body fluids and tissues in children and in adults. Clin Chim Acta 187:317–328
Tracey BM, Cheng KN, Rosankiewicz J, Stacey TE, Chalmers RA (1988) Urinary C6−C12 dicarboxylic acylcarnitines in Reye's syndrome. Clin Chim Acta 175:79–88
Vamecq J, De Hoffmann E, Van Hoof E (1985) The microsomal dicarboxylyl CoA synthetase. Biochem J 230: 683–693
Winter SC, Zorn EM, Vance WH (1990) Carnitine deficiency. Lancet I: 981–982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Böhles, H., Evangeliou, A., Bervoets, K. et al. Carnitine esters in metabolic disease. Eur J Pediatr 153 (Suppl 1), S57–S61 (1994). https://doi.org/10.1007/BF02138779
Issue Date:
DOI: https://doi.org/10.1007/BF02138779